KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Short-Term Debt repayments (2021 - 2025)

Elanco Animal Health (ELAN) has disclosed Short-Term Debt repayments for 5 consecutive years, with $85.0 million as the latest value for Q2 2025.

  • Quarterly Short-Term Debt repayments fell 57.5% to $85.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $125.0 million through Dec 2025, down 35.9% year-over-year, with the annual reading at $125.0 million for FY2025, 35.9% down from the prior year.
  • Short-Term Debt repayments hit $85.0 million in Q2 2025 for Elanco Animal Health, up from $40.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $813.0 million in Q4 2022 to a low of -$738.0 million in Q3 2022.
  • Historically, Short-Term Debt repayments has averaged $104.1 million across 5 years, with a median of $85.0 million in 2025.
  • Biggest YoY gain for Short-Term Debt repayments was 1050.0% in 2022; the steepest drop was 838.0% in 2022.
  • Year by year, Short-Term Debt repayments stood at $100.0 million in 2021, then surged by 713.0% to $813.0 million in 2022, then plummeted by 93.48% to $53.0 million in 2023, then tumbled by 52.83% to $25.0 million in 2024, then skyrocketed by 240.0% to $85.0 million in 2025.
  • Business Quant data shows Short-Term Debt repayments for ELAN at $85.0 million in Q2 2025, $40.0 million in Q1 2025, and $25.0 million in Q4 2024.